{
    "clinical_study": {
        "@rank": "35105", 
        "arm_group": [
            {
                "arm_group_label": "Post surgery without glaucoma drops", 
                "arm_group_type": "Active Comparator", 
                "description": "This will be for the group that had gas duration surgery using SF6 (Sulfur Hexafluoride) or C3F8 (perfluoropropane gas tamponade)  and only uses the standard post-operative topical drops."
            }, 
            {
                "arm_group_label": "Post surgery with glaucoma drops", 
                "arm_group_type": "Experimental", 
                "description": "This will be for the group that had gas duration surgery (using SF6 or C3F8). In addition to the standard post-operative topical drops, glaucoma drops, Timolol-dorzolamide (timolol 0.5%-dorzolamide 2%) will be given."
            }
        ], 
        "brief_summary": {
            "textblock": "A controlled clinical study comparing the effect of topical aqueous suppressants on\n      intraocular gas duration."
        }, 
        "brief_title": "The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Scleral Buckling", 
        "detailed_description": {
            "textblock": "A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on\n      Intraocular Gas Duration following Scleral Buckling and Pneumatic Retinopexy"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ability to provide written informed consent and comply with study assessments for the\n             full duration of the study.\n\n          -  Have undergone eye surgery including scleral buckling or pneumatic retinopexy for\n             treatment of retinal detachment other condition at the discretion of the\n             investigator.\n\n        Exclusion Criteria:\n\n          -  Prior surgery to treat glaucoma.\n\n          -  Current use of glaucoma eye drops.\n\n          -  Absence of a lens in the eye or presence of a lens implant in front of the iris\n             (colored part of your eye).\n\n          -  Allergy or contraindication to any of the glaucoma drops being used in this study\n             (e.g., sulfa allergy, asthma, chronic obstructive pulmonary disease (bronchitis or\n             emphysema), slow heart rate)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01843920", 
            "org_study_id": "11095 Gas Duration", 
            "secondary_id": "11-095"
        }, 
        "intervention": [
            {
                "arm_group_label": "Post surgery with glaucoma drops", 
                "description": "Patients will receive the standard post-operative drops regardless of what group you are in. The glaucoma drops will only be given to the experimental group.", 
                "intervention_name": "Timolol-dorzolamide (Glaucoma drops)", 
                "intervention_type": "Drug", 
                "other_name": [
                    "timol", 
                    "glaucoma drops", 
                    "dorzolamide", 
                    "timol-dorzolamide"
                ]
            }, 
            {
                "arm_group_label": [
                    "Post surgery without glaucoma drops", 
                    "Post surgery with glaucoma drops"
                ], 
                "description": "Patients will receive the standard post-operative drops regardless of what group ther are in. The standard post-operative drops are Prednisolone acetate,Polymyxin B and Trimethoprim", 
                "intervention_name": "standard post-operative topical drops", 
                "intervention_type": "Drug", 
                "other_name": [
                    "glaucoma", 
                    "drops", 
                    "standard of care", 
                    "oral", 
                    "corticosteroid", 
                    "prednisolone", 
                    "Polymyxin B", 
                    "trimethoprim"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Polymyxin B", 
                "Polymyxins", 
                "Trimethoprim", 
                "Timolol", 
                "Dorzolamide", 
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Prednisolone", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "eye", 
            "pneumatic retinopexy", 
            "topical"
        ], 
        "lastchanged_date": "May 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19107"
                }, 
                "name": "Mid Atlantic Retina- Wills Eye Institute"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on Intraocular Gas Duration Following Scleral Buckling and Pneumatic Retinopexy.", 
        "overall_official": {
            "affiliation": "Wills Eye Institute", 
            "last_name": "Jason Hsu, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "This will be reported by the patient when they see/feel the gas bubble disappear.", 
            "measure": "Complete resolution of intraocular gas bubble", 
            "safety_issue": "No", 
            "time_frame": "Following surgery, until gas bubble is gone. Up to 2 months."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01843920"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Wills Eye", 
            "investigator_full_name": "Brian Burke, MPH", 
            "investigator_title": "Investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "The normal intraocular pressure range is 10-21 mm Hg", 
            "measure": "Return of intraocular pressure to normal levels", 
            "safety_issue": "No", 
            "time_frame": "Post-op Day 1, Week 1, Month 1, Month 2, Month 4"
        }, 
        "source": "Wills Eye", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Brian Burke, MPH", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}